Concepedia

Atsushi Hosui

AH

40

Publications

2.9K

Citations

27

H-Index

2000

Active since

Affiliations

The University of Osaka(Current)

Kansai Rosai Hospital

National Institute of Diabetes and Digestive and Kidney Diseases

National Institutes of Health

Osaka Rosai Hospital

Atsushi Hosui is an author at The University of Osaka specializing in medicine, hepatology, and cell biology.

ORCID

Top concepts

Publications per year

2000–2021

40

Publications

40

The let-7 family of microRNAs inhibits Bcl-xL expression and potentiates sorafenib-induced apoptosis in human hepatocellular carcinoma

Satoshi Shimizu, Tetsuo Takehara, Hayato Hikita et al. · Journal of Hepatology · 2010 · 342 citations

, , +13

Inhibition of autophagy potentiates the antitumor effect of the multikinase inhibitor sorafenib in hepatocellular carcinoma

Satoshi Shimizu, Tetsuo Takehara, Hayato Hikita et al. · International Journal of Cancer · 2011 · 259 citations

Loss of signal transducer and activator of transcription 5 leads to hepatosteatosis and impaired liver regeneration†

Yongzhi Cui, Atsushi Hosui, Rui Sun et al. · Hepatology · 2007 · 184 citations · Full text

Increases in p53 expression induce CTGF synthesis by mouse and human hepatocytes and result in liver fibrosis in mice

Takahiro Kodama, Tetsuo Takehara, Hayato Hikita et al. · Journal of Clinical Investigation · 2011 · 161 citations

, , +20

The Bcl-Xl Inhibitor, ABT-737, Efficiently Induces Apoptosis and Suppresses Growth of Hepatoma Cells in Combination with Sorafenib

Hayato Hikita, Tetsuo Takehara, Satoshi Shimizu et al. · Hepatology · 2010 · 149 citations · Full text

Rows per page

1–5 of 40